Togashi Y - Search Results

1

Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance.

Zhu J, Wu W, Togashi Y, Taira Nihira N, Johmura Y, Zhu D, Nakanishi M, Miyoshi Y, Ohta T. Zhu J, et al. Among authors: togashi y. Breast Cancer. 2022 Nov;29(6):1076-1087. doi: 10.1007/s12282-022-01389-3. Epub 2022 Jul 27. Breast Cancer. 2022. PMID: 35882754 Free PMC article.

2

HP1 regulates the localization of FANCJ at sites of DNA double-strand breaks.

Wu W, Togashi Y, Johmura Y, Miyoshi Y, Nobuoka S, Nakanishi M, Ohta T. Wu W, et al. Among authors: togashi y. Cancer Sci. 2016 Oct;107(10):1406-1415. doi: 10.1111/cas.13008. Epub 2016 Sep 1. Cancer Sci. 2016. PMID: 27399284 Free PMC article.

3

HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA.

Wu W, Rokutanda N, Takeuchi J, Lai Y, Maruyama R, Togashi Y, Nishikawa H, Arai N, Miyoshi Y, Suzuki N, Saeki Y, Tanaka K, Ohta T. Wu W, et al. Among authors: togashi y. Cancer Res. 2018 Nov 15;78(22):6371-6385. doi: 10.1158/0008-5472.CAN-18-1877. Epub 2018 Oct 2. Cancer Res. 2018. PMID: 30279242

4

HERC2 regulates RPA2 by mediating ATR-induced Ser33 phosphorylation and ubiquitin-dependent degradation.

Lai Y, Zhu M, Wu W, Rokutanda N, Togashi Y, Liang W, Ohta T. Lai Y, et al. Among authors: togashi y. Sci Rep. 2019 Oct 3;9(1):14257. doi: 10.1038/s41598-019-50812-x. Sci Rep. 2019. PMID: 31582797 Free PMC article.

5

HERC2 inactivation abrogates nucleolar localization of RecQ helicases BLM and WRN.

Zhu M, Wu W, Togashi Y, Liang W, Miyoshi Y, Ohta T. Zhu M, et al. Among authors: togashi y. Sci Rep. 2021 Jan 11;11(1):360. doi: 10.1038/s41598-020-79715-y. Sci Rep. 2021. PMID: 33432007 Free PMC article.

6

Ribosomal S6 kinase (RSK) plays a critical role in DNA damage response via the phosphorylation of histone lysine demethylase KDM4B.

Wu W, Zhu J, Nihira NT, Togashi Y, Goda A, Koike J, Yamaguchi K, Furukawa Y, Tomita T, Saeki Y, Johmura Y, Nakanishi M, Miyoshi Y, Ohta T. Wu W, et al. Among authors: togashi y. Breast Cancer Res. 2024 Oct 21;26(1):146. doi: 10.1186/s13058-024-01901-x. Breast Cancer Res. 2024. PMID: 39434131 Free PMC article.

7

Nuclear PD-L1 triggers tumour-associated inflammation upon DNA damage.

Nihira NT, Wu W, Hosoi M, Togashi Y, Sunada S, Miyoshi Y, Miki Y, Ohta T. Nihira NT, et al. Among authors: togashi y. EMBO Rep. 2025 Feb;26(3):635-655. doi: 10.1038/s44319-024-00354-9. Epub 2025 Jan 2. EMBO Rep. 2025. PMID: 39747659 Free PMC article.

8

TGF-β Inhibitor Potentiates Osimertinib-Induced Anti-Tumor Immunity in Egfr-Mutant Lung Cancer.

Kuribayashi T, Nishimura J, Okawa S, Taoka M, Mori S, Tanaka T, Nishimura T, Morita A, Hara N, Ninomiya K, Makimoto G, Rai K, Ichihara E, Hotta K, Togashi Y, Maeda Y, Kiura K, Ohashi K. Kuribayashi T, et al. Among authors: togashi y. Cancer Sci. 2026 Feb 27. doi: 10.1111/cas.70352. Online ahead of print. Cancer Sci. 2026. PMID: 41757675 Free article.

9

[Mitochondria in Cancer and Immunity].

Taki T, Morinaga T, Togashi Y. Taki T, et al. Among authors: togashi y. Gan To Kagaku Ryoho. 2026 Feb;53(2):73-79. Gan To Kagaku Ryoho. 2026. PMID: 41748505 Review. Japanese.

10

Prognostic significance of peripheral myeloid-derived suppressor cells in advanced breast cancer.

Kanaoka H, Nagahashi M, Tsuchida J, Kuroiwa M, Urano S, Komatsu M, Yoshida S, Oshiro A, Sugimoto G, Mitsuyoshi A, Togashi Y, Hattori A, Higuchi T, Nishimukai A, Shimoda M, Miyoshi Y. Kanaoka H, et al. Among authors: togashi y. Breast Cancer. 2026 Feb 23. doi: 10.1007/s12282-026-01831-w. Online ahead of print. Breast Cancer. 2026. PMID: 41729431 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters